contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


the-nomination-committees-proposal-for-the-board-of-directors-of-apotea-ab-publ-1

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Apotea is active in the e-commerce sector. The company operates as an online pharmacy. The company sells and supplies a wide range of prescription and over-the-counter medicines, skin and hair care products as well as make-up and various beauty-related products. The company operates in the Swedish domestic market, where the customer base mainly consists of private individuals. Apotea was founded in 2003 and has its headquarters in Stockholm.

Apotea

Ahead of the annual general meeting of Apotea AB (publ) (“Apotea”) on May 26, 2026, the Nomination Committee hereby announces its proposal regarding the Chairman of the Board and other members...

<div class="mfn-preamble"><p><strong>Ahead of the annual general meeting of Apotea AB (publ) (“Apotea”) on May 26, 2026, the Nomination Committee hereby announces its proposal regarding the Chairman of the Board and other members of the Board.</strong></p></div><div class="mfn-body"><p>The Nomination Committee proposes that Cecilia Qvist, Anders Eriksson, Monica Lindstedt, Per Schlingmann and Pär Svärdson are re-elected as members of the Board of Directors and that Eva Nilsagård and Johan Lundgren are elected as new members of the Board of Directors of Apotea. Furthermore, the Nomination Committee proposes re-election of Cecilia Qvist as Chairman of the Board. Joanna Hummel left the board on February 4, 2026, to take up an operational role in Apotea. Jonas Hagströmer has informed the Nomination Committee that he declines re-election. The Nomination Committee's proposal means that the number of Board members will remain at seven.</p><p>Eva Nilsagård (born 1964) has over 30 years’ experience in senior roles within finance and business development, ranging from large international groups to smaller, entrepreneur-led companies. She has extensive experience of major organisational changes and several initial public offerings, including listings on the Nasdaq Main Market, and currently serves on a number of boards, where she chairs the audit committee.</p><p>Johan Lundgren (born 1983) has worked at H&amp;M on several occasions since 2008 and has held roles in sales, business development and operations, both globally and locally. Following a period as Chief Operating Officer at Fortnox, he returned to H&amp;M in 2024, where he is currently responsible for strategy and innovation in his role as Chief Strategy and Innovation Officer.</p><p>All of the Nomination Committee's proposals will be presented in the notice to the Annual General Meeting and the proposals and the reasoned statement for the proposed composition of the Board of Directors will also be available on the company's website at the same time.</p><p>The Nomination Committee for the 2026 Annual General Meeting consists of Camilla Günesli appointed by Laulima AB, Chair of the Nomination Committee, Karin Cederbaum appointed by Alecta Tjänstepension Ömsesidigt, Björn Henriksson appointed by Nordea fonder, Christopher Beaven appointed by WCM Investment Management, and Cecilia Qvist, Chair of the Board.</p></div><div class="mfn-footer mfn-contacts mfn-b12d6662ed35"><p><strong class="mfn-heading-1">For further information, please contact:</strong><br>Stefan Eriksson, deputy CEO, press &amp; Investor Relations <br>E-mail: ir@apotea.se</p></div><div class="mfn-footer mfn-about mfn-42c70b3e06c2"><p><strong class="mfn-heading-1">About Apotea</strong><br>Apotea is Sweden’s leading online pharmacy with the ambition to become the pharmacy of tomorrow by continuously simplifying and enhancing the customer experience. With the widest assortment on the market, low prices and fast deliveries, Apotea facilitates everyday life for its three million active customers. In E-barometern’s 2025 customer survey, Apotea was ranked as the customers’ favourite e-commerce store for the eighth consecutive year. Since 2022, the group also operates in Norway through its Norwegian subsidiary Apotera.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a class="mfn-primary" href="https://storage.mfn.se/41a6eed4-9292-41c4-a0eb-74bd6b65ccc2/the-nomination-committees-proposal-for-the-board-of-directors-of-apotea-ab-publ.pdf" rel="noopener">The Nomination Committee's proposal for the Board of Directors of Apotea AB (publ)</a></p></div>

The Nomination Committee's proposal for the Board of Directors of Apotea AB (publ)

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Nordea Bank

Aktionær i Nordea? Det er nemmere end nogensinde at deltage i Nordeas generalforsamling takket være nyt digitalt setup

Return on capital (ROE, ROI, ROIC, RONIC)

Balance sheet, debt leverage and risks